OM
Outset Medical, Inc.NASDAQHealthcare$4.01+4.43%ClosedMarket Cap: $73.4M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.57
P/S
0.63
EV/EBITDA
-2.37
DCF Value
$-69.99
FCF Yield
-63.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
39.1%
Operating Margin
-55.6%
Net Margin
-68.3%
ROE
-55.0%
ROA
-30.9%
ROIC
-29.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $28.9M | 42.4% | $-17.3M | $-19.5M | $-1.09 | — |
| FY 2025 | $119.5M | 39.1% | $-66.7M | $-81.7M | $-5.37 | — |
| Q3 2025 | $29.4M | 39.4% | $-15.8M | $-17.8M | $-1.00 | — |
| Q2 2025 | $31.4M | 37.8% | $-16.9M | $-18.5M | $-1.04 | — |
| Q1 2025 | $29.8M | 37.2% | $-16.4M | $-25.8M | $-7.44 | — |
| Q4 2024 | $29.5M | 36.5% | $-21.9M | $-25.6M | $-7.35 | — |
| FY 2024 | $113.7M | 33.9% | $-113.4M | $-128.0M | $-36.95 | — |
| Q3 2024 | $28.7M | 34.3% | $-23.8M | $-27.9M | $-8.30 | — |
| Q2 2024 | $27.4M | 35.7% | $-30.8M | $-34.5M | $-9.96 | — |
| Q1 2024 | $28.2M | 29.2% | $-36.9M | $-39.9M | $-11.77 | — |
| Q4 2023 | $30.5M | 25.3% | $-37.4M | $-38.6M | $-0.77 | — |
| FY 2023 | $130.4M | 22.2% | $-169.8M | $-172.8M | $-52.27 | — |